Summary
ARDANA, the biotechnology company that plans to float next month, will use its new status to target acquisitions across Europe.
The company last week confirmed long-expected plans to list on the London Stock Exchange which would raise up to GBP 25m and value Ardana at GBP 80m.See the full content of this document
Extract
Ardana Cash Injection to Boost Acquisitions
Graham Lee, the company's finance director, said about 13 per cent of Ardana's new cash pile - including GBP 11m in t...
See the full content of this document
Sponsored links
